203 related articles for article (PubMed ID: 17826886)
1. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma.
Ma Y; Ye F; Lv W; Cheng Q; Chen H; Xie X
Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):204-11. PubMed ID: 17826886
[TBL] [Abstract][Full Text] [Related]
2. [Study of apoptosis and Fas expression of peritoneal fluid and peripheral blood T lymphocytes in patients with epithelial ovarian cancer and their relationship with CA125].
Ma YX; Ye F; Chen HZ; Lü WG; Xie X
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):734-9. PubMed ID: 17565840
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble fas level as a prognostic factor in patients with gynecological malignancies.
Konno R; Takano T; Sato S; Yajima A
Clin Cancer Res; 2000 Sep; 6(9):3576-80. PubMed ID: 10999747
[TBL] [Abstract][Full Text] [Related]
4. Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis.
Baldwin RL; Tran H; Karlan BY
Gynecol Oncol; 1999 Aug; 74(2):265-71. PubMed ID: 10419743
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
Rabinowich H; Reichert TE; Kashii Y; Gastman BR; Bell MC; Whiteside TL
J Clin Invest; 1998 Jun; 101(11):2579-88. PubMed ID: 9616229
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
7. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
8. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
Taylor DD; Gerçel-Taylor C; Lyons KS; Stanson J; Whiteside TL
Clin Cancer Res; 2003 Nov; 9(14):5113-9. PubMed ID: 14613988
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
10. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M
J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948
[TBL] [Abstract][Full Text] [Related]
11. Expression of Fas ligand and sFas ligand in human gastric adenocarcinomas.
Lim SC
Oncol Rep; 2002; 9(1):103-7. PubMed ID: 11748465
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
[TBL] [Abstract][Full Text] [Related]
13. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand.
Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G
Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
[TBL] [Abstract][Full Text] [Related]
15. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
[TBL] [Abstract][Full Text] [Related]
16. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
Onalan G; Selam B; Baran Y; Cincik M; Onalan R; Gündüz U; Ural AU; Pabuccu R
Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment.
Pignataro L; Arisi E; Sambataro G; Corsi MM
J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205
[TBL] [Abstract][Full Text] [Related]
18. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
Kassouf N; Thornhill MH
Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
[TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis.
Grzegorczyk J; Kowalski ML; Pilat A; Iwaszkiewicz J
Mediators Inflamm; 2002 Aug; 11(4):225-33. PubMed ID: 12396474
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
Wang WS; Chen PM; Wang HS; Liang WY; Su Y
Carcinogenesis; 2006 May; 27(5):1113-20. PubMed ID: 16474169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]